www.nypost.com

www.nypost.com
Share

www.nypost.com

 •  October 31

A multiyear civil investigation by 45 states into alleged price-fixing of 15 generic drugs widened dramatically on Tuesday to include the No. 2 executive at pharmaceutical giant Mylan. The state attorneys general are looking to sue Mylan President Rajiv Malik, court papers show. If the states get court permission to widen their case, Malik would be...

www.nypost.com

 •  August 31

US health regulators have approved a revolutionary new drug that uses a patient’s own cells to fight cancer – but it costs $475,000. Pharma giant Novartis on Wednesday won highly anticipated US approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, an exhorbitantly priced treatment that nevertheless marks the...

www.nypost.com

 •  March 31

Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the...

www.nypost.com

 •  February 14

By Post Staff Report Bottles of Tylenol sold in the US will soon bear red warnings alerting users to the potentially fatal risks of taking too much of the popular pain reliever. The unusual step, disclosed by the company that makes Tylenol, comes amid a growing number of lawsuits and pressure from the federal government that could have widespread...